Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SEH1-like nucleoporin (SEH1L) is a scaffold protein that is a core component of the nuclear pore complex (NPC), specifically part of the Nup107-160 subcomplex essential for nuclear-cytoplasmic transport, mitotic spindle formation, and chromosome segregation[1][3][5]. SEH1L also participates in the GATOR2 complex, which regulates the amino acid-sensing mTORC1 signaling pathway, impacting cell growth, proliferation, and differentiation[2][3][4]. Through its roles in both the nuclear pore and GATOR2, SEH1L coordinates multiple aspects of cellular physiology, including cell division, nutrient signaling, and brain development, although it is not considered a direct therapeutic drug target. SEH1L dysfunction has been linked to specific diseases such as congenital nail abnormalities and has regulatory connections to cancer and neurodevelopmental disorders via the mTORC1 pathway[2][3][4]. The protein is highly conserved across eukaryotes and has structural similarity to yeast Seh1 and Sec13[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SEH1-like nucleoporin (SEH1L).